3Groenning BA, Nilsson JC, Sondergaard L, et al. Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure. J Am Coll Cardiol, 2000,36:2072-2080.
4Second Chinese Cardiac Study (CCS-2) Collaborative Group. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group. J Cardiovasc Risk, 2000,7:435-441.
5Torre-Amione G, Kapadia S, Lee J, et al. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation, 1996,93:704-711.
6Testa M, Yeh M, Lee P, et al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol, 1996,28:964-971.
8Hosenpud JD, Campbell SM, Mendelson DJ. Interleukin-1-induced myocardial depression in an isolated beating heart preparation. J Heart Transplant, 1989,8:460-464.
9Lapointe N, Blais C Jr, Adam A, et al. Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat. J Am Coll Cardiol, 2002,39:1692-1698.
10Deten A, Volz HC, Briest W, et al. Differential cytokine expression in myocytes and non-myocytes after myocardial infarction in rats. Mol Cell Biochem, 2003,242(1-2):47-55.
10Potteaux S,Esposito B, Oostrom O, et al.Leukocyte--derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice [J]. Arterioscler Thromb Vasc Biol, 2004, 24(8): 1474--1478.
